An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
Active, not recruiting · NCT05500092 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer | Resectable Stage IIA to IIIB Non-small Cell Lung Cancer | Active, not recruiting | Phase 2 | 2026-10-06 | NCT05500092 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| American Cancer Society, Inc. | 60 |
| Bristol-Myers Squibb | 422 |
| Montefiore Medical Center | 93 |
| Penn State University | 92 |
| Washington University School of Medicine | 475 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Montefiore Medical Center-Albert Einstein College of Medicine | The Bronx | United States | 1 |
| Penn State Health Milton S. Hershey Medical Center | Hershey | United States | 31 |
| Washington University in St. Louis | St Louis | United States | 35 |
| White Plains Hospital (WPH) | White Plains | United States | 1 |